Bristol Myers Squibb has grown revenue 2.9% a year over three years and 2.1% a year over five, with earnings per share compounding at 6.5%. Revenue growth, 3-year annual rate: +2.9% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +2.1%, growth has picked up over the last three years. Earnings per share, 3-year rate: +6.5%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

BMYBristol Myers Squibb

Healthcare

$59.11+34% 1Y

$59.11

$41.6752 weeks$68.08

Is it growing?

Good

Growing: earnings up +83% year on year and operating margin widening (+10.1 points).

2 good, 1 neutral

Revenue trend+3% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Earnings trend+83% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+10.1 points operating

Trailing-twelve-month operating margin, 24.2% now against 14.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BMY growing?

Bristol Myers Squibb has grown revenue 2.9% a year over three years and 2.1% a year over five, with earnings per share compounding at 6.5%.

+2.9%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.1%
Revenue growth, 5-year rate · +2.9% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +6.5%
Earnings per share, 3-year rate · revenue +2.9% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed